Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer? - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles International Journal of Cancer Year : 2016

Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?

Dates and versions

pasteur-01499032 , version 1 (30-03-2017)

Identifiers

Cite

Eduardo Osinaga, Teresa Freire, Luis Ubillos. Author's reply to: Could cross-immunological reactivity to Trypanosoma cruzi antigens be considered a rational strategy for designing vaccines against cancer?. International Journal of Cancer, 2016, 139 (9), pp.2144. ⟨10.1002/ijc.30246⟩. ⟨pasteur-01499032⟩
17 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More